Physician profile
Jacob Nunamaker
NPI 1356411508
$4,787.81
in general payments reported to CMS, 2019-2025
21 companies · $543 in 2025
The $543 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $636 · 2021: $682 · 2022: $722 · 2023: $358 · 2024: $643 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,544.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,339.36 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $738.52 | 2019-2025 | General - Molecular Intervention, General - Balloon Catheters, General - Ultrasound |
| Cardiovascular Systems INC. | $691.29 | 2019-2022 | |
| Medtronic, INC. | $451.95 | 2021-2025 | Ffrangio, Symplicity G3, Onyx Frontier |
| Terumo Medical Corporation | $332.42 | 2020-2024 | Glidewire |
| Novartis Pharmaceuticals Corporation | $196.59 | 2019-2024 | |
| Abiomed | $161.37 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $154.10 | 2019-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $141.07 | 2019 | |
| Amgen INC. | $97.53 | 2019 | |
| Medtronic Vascular, INC. | $88.09 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $81.67 | 2019 | |
| Novo Nordisk INC | $69.30 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $51.73 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $48.92 | 2024 | Assure Wcd |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $41.70 | 2025 | |
| Pfizer INC. | $23.47 | 2019-2020 | |
| Cardiva Medical, INC. | $22.94 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.11 | 2019 | |
| Bracco Diagnostics INC. | $20.16 | 2019 | |
| Cardinal Health 200 LLC | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Nunamaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.